antigen testing
Avacta Pauses Sales of Antigen Test
Avacta is pulling its AffiDX SARS-CoV-2 antigen lateral flow test from the market while it works to improve the assay's detection sensitivity.
Quidel Preliminary Q4 Revenues Drop 21 Percent, Beat Estimates
For the fourth quarter of 2021, the firm expects COVID-19 revenues of approximately $510 million and total revenues of $633 million to $637 million.
Top 10 Articles on 360Dx in 2021
Not surprisingly, the year in diagnostics was dominated by COVID-19 testing, particularly the growing at-home antigen test market.
MilliporeSigma Gets $136.7M US Contract for Lateral Flow Tech Production
The three-year contract is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness.Â
Roche Obtains FDA Emergency Use Authorization for COVID-19 Antigen Self-Test
The company said upon the US launch of its test in January, it has the capacity to produce tens of millions of tests per month to help support the pandemic response.
Nov 30, 2021
Nov 3, 2021
OraSure Technologies Q3 Revenues Rise 12 Percent
Oct 27, 2021